完整後設資料紀錄
DC 欄位語言
dc.contributor.authorChan, ECen_US
dc.contributor.authorChang, CAen_US
dc.contributor.authorWu, TZen_US
dc.contributor.authorLin, YLen_US
dc.date.accessioned2019-04-02T05:58:56Z-
dc.date.available2019-04-02T05:58:56Z-
dc.date.issued1998-11-01en_US
dc.identifier.issn0141-5492en_US
dc.identifier.urihttp://dx.doi.org/10.1023/A:1005469929961en_US
dc.identifier.urihttp://hdl.handle.net/11536/148035-
dc.description.abstractThe normal human epidermal keratinocyte (NHEK) was used to evaluate the cytotoxicity of recombinant lysostaphin. As determined with the Neutral Red (NR) cytotoxicity assay, the midpoint toxicity value (NR50) after 48 h exposure was 16 +/- 0.4 g lysostaphin/l. Lysostaphin cytotoxicity effect is much less than the surface active agent, sodium laurate. However, the NR,, value after 48-h exposure was 1.9 +/- 0.02 g/l for S. aureus lysate derived from the bacterial lytic action of lysostaphin. A linear increase in interleukin-8 (IL-8) level in NHEK cells from resting levels of 65 +/- 3 pg/ml to peak of 760 +/- 15 pg/ml during the first 9 hours was noted for the cells treated with 800 mg lysostaphin/l. S. aureus lysate has the same effect on the induction of IL-8 levels. The induced rises in IL-8 were lysostaphin and S. aureus lysate concentration dependence.en_US
dc.language.isoen_USen_US
dc.subjectrecombinant lysostaphinen_US
dc.subjectcytotoxicityen_US
dc.subjectinterleukin-8en_US
dc.titleEffects of recombinant lysostaphin on cytotoxicity and interleukin-8 level in normal human epidermal keratinocytes cell lineen_US
dc.typeArticleen_US
dc.identifier.doi10.1023/A:1005469929961en_US
dc.identifier.journalBIOTECHNOLOGY LETTERSen_US
dc.citation.volume20en_US
dc.citation.spage1053en_US
dc.citation.epage1056en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.identifier.wosnumberWOS:000077617200011en_US
dc.citation.woscount1en_US
顯示於類別:期刊論文